Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation With Post-transplant Cyclophosphamide in Patients With Acquired Refractory Aplastic Anemia or in Relapse After Immunosuppression

Clinical trial NCT05126849 · RECRUITING

Trial details

NCT number

NCT05126849

Sponsor

Assistance Publique - Hôpitaux de Paris

Status

RECRUITING

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2022-01-06

Primary completion

2027-01-06

Enrollment

31

View on ClinicalTrials.gov